moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
Published 1 year ago • 151 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
4:02
moving car-t therapy into earlier lines of treatment for myeloma and the need for effective bridging
-
1:54
ongoing car-t trials in earlier lines of therapy in myeloma & strategies to improve efficacy
-
2:03
car-t therapy in myeloma: moving into earlier lines and treating patients with unmet medical needs
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
2:18
moving forward: bringing car-t therapy to a frontline setting in myeloma
-
2:42
clinical indications for car-t therapy in dlbcl & the possibility of moving car-t into earlier lines
-
1:46
car-t therapy vs bites in multiple myeloma: current outlooks & the importance of patient selection
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
2:30
moving car t-cell therapies to earlier lines of therapy in multiple myeloma
-
3:47
what is car t-cell therapy?
-
14:10
highlights in multiple myeloma: improving access to car-t therapy, novel targets & future outlooks
-
2:16
moving car-t therapy into the frontline setting in myeloma: insights into cartitude-5 & cartitude-6
-
3:43
the future of car-t therapy
-
1:38
challenges of car-t therapy in the real-world setting
-
2:37
moving forwards with car t-cells in myeloma
-
1:57
car t-cell therapy in myeloma
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
0:50
the fast-changing field of car-t therapy
-
1:42
unanswered questions in car-t therapies